Friday, Oct. 30, 2026 · about a 5-minute read
Good morning. Yesterday a nuclear reactor that ships on a truck switched on, an AI-designed cancer pill shrank tumors in people, and a heat cloak hid objects in three dimensions. Today leans into The End of Aging, starting with the one below.
The big one
AI could unlock a real tan without the sun, or the sun damage. In 2017, Massachusetts General Hospital researchers showed that a rub-on molecule could darken living human skin in a lab dish with the body's own pigment, no sunlight required. In red-haired mice it produced a tan that turned nearly jet black in a day or two. Nine years later, no person has tried it, because the molecule blocks enzymes the whole body uses, and that is exactly the kind of design problem AI drug-design tools are getting good at solving.
Why it matters: a real tan is the skin's own sun shield. A safe one in a tube could mean fewer burns and, researchers hope, fewer skin cancers, and it would replace the black-market "Barbie drug" injections the Skin Cancer Foundation warned about in July. Read it →
Yesterday on the site
The End of Disease
One Infusion Could End a Lifetime of Inherited Kidney Stones: one dose of a gene editor cut the stone-forming compound by up to 61.8% a year later, pointing toward a single treatment in place of lifelong care.
A Cheap Pill May Shield Some Brains From Dementia, and a Gene Test Could Tell Whose: a re-analysis of a 13,500-person trial points dementia prevention toward cheap drugs matched to your genes.
A Birth Control Pill Men Take Only When Needed Heads for Safety Tests: a hormone-free pill taken 30 minutes before sex won $8.2 million to start its safety tests.
One Gene Fix Could Save Sight for Children Born Going Blind: the FDA cleared the first human trial, with dosing planned by the end of the year.
AI-Made Medicine Shrinks Tumors in First Human Tests: by the company's account, the first sign that a molecule designed by generative AI can work in people.
Custom Gene Fixes for a Single Patient Get an FDA Fast Lane: one license could cover many patient-specific versions of a gene editor, which is what makes one-person cures practical.
Limitless Energy
Fusion Plants Could Double as Gold Mines by Turning Mercury Into Gold: selling gold on the side could help pay for fusion power before electricity alone can.
A Nuclear Reactor That Ships on a Truck Has Switched On: factory-built reactors could deliver power wherever the grid ends, at the scale a Moon base would need.
To the Stars
Delivery to Humanity's First Permanent Moon Base Could Launch This Year: NASA expects the first launch by the end of 2026, and the race is over whose lander is ready first.
Robots & Self-Driving
The International Robot Race Heats Up: new limits on foreign-made robots hand the early American market to American-built machines.
Thinking Machines
Google's New AI Is So Good at Hacking That Only the Good Guys Get It: three leading AI labs now hand their strongest hacking-capable models to defenders first.
Sci-Fi Tech
Heat Invisibility Cloaks Now Work in 3D: a 3D-printed lattice hid objects from an infrared camera, a real piece of the sci-fi invisibility cloak.
Some Assembly Required
The Week-Long Cure: Medicines Could Be Designed in Days and Tested on a Digital You: four technologies that already exist could snap together into a pipeline that takes a disease to a tested candidate in weeks.
Already up this morning
Fully Robotic Cars With No Steering Wheel Are Heading to Dallas: Tesla says its pedal-free Cybercab reaches a second city in November.
Electric Cars Could Double Their Driving Range: the world's biggest battery maker doubled the size of its liquid-free test cells.
A Pill That Could Slow Alzheimer's Gets Its Verdict in Weeks: a once-daily pill that lowers stress hormone inside brain cells reports its pivotal results in mid-November.
By the numbers
150 days: how long Deployable Energy says its truckable reactor took to go from project start to a self-sustaining chain reaction.
4 of 22: mesothelioma patients whose tumors shrank substantially on an AI-designed pill in its first human trial, two of them after five and six earlier treatments had failed (company data).
318,484: protein designs an AI model generated against scorpion toxins in 64 hours.
New on the odds board
Yesterday's posts added fresh odds on the first person treated with a gene fix for RDH12 childhood blindness, a reactor that runs at full power after riding on a truck, Cybercabs carrying riders in Dallas, and an AI-designed cancer pill reaching U.S. approval. Paid readers see the numbers inside each post.
On the calendar
Today, Oct. 30: Tesla's sworn answers to federal safety regulators on how a car with no brake pedal meets the rules are due (date per Tesla North and a third-party tracker, unconfirmed by NHTSA).
Sunday, Nov. 1: NASA's new space nuclear power agreement with the Energy Department takes effect.
Nov. 8 and 9: first looks at two one-dose cholesterol and triglyceride gene editors, from Editas (monkey data) and CRISPR Therapeutics (human data).
Mid-November: results for the Xanamem Alzheimer's pill, then on Nov. 16 Phase 3 results for a second Alzheimer's pill, AriBio's AR1001, from 1,535 people.
The story we're following
Digital patients: a Copenhagen start-up says its virtual patients called 5 of 6 drug trials in advance, by its own count. No regulator has yet let a computer stand in for real patients in a final trial, and we're watching for the first one that does.
Quote of the day
"We've shown that a true 3D omnidirectional thermal cloak is possible." — Xiaojia Shelly Zhang, lead researcher, University of Illinois Urbana-Champaign
Coming up today
9 AM: Full-color screens now fit in sunglasses
10 AM: Air taxis just got their first federal permit
11 AM: A nose spray for Alzheimer's has finished its trial
Noon: Age-reversal therapy clears its first safety test in humans
1 PM: Old-age weakness may have switches scientists can flip
2 PM: AI found a gene that let old mice live longer
3 PM: Did AI just overturn a rule hundreds of computer science papers rely on? Experts are checking
4 PM: A $500 million bet on batteries that need no lithium
5 PM: Immune cells could be trained to kill aging's "zombie" cells
6 PM: Hormones steer how skin renews, a new clue to keeping it young
See you tomorrow
That's today in the future. If someone you know would want to wake up to this, forward it to them, and if you're reading a forward, subscribe here. It's free every morning.